The hemodynamically significant ductus arteriosus in critically Ill full-term neonates: Two case reports?

Neonatology

Volumn 91, Issue 4, 2007, Pages 260-265

  Ly, Linh G ^a   Hawes, Judith ^a   Whyte, Hilary E ^a   Teixeira, Lilian S ^a   McNamara, Patrick J ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Heart failure; Myocardial function; Patent ductus arteriosus; Pulmonary hypertension; Pulmonary overcirculation

Indexed keywords

INDOMETACIN;

ARTICLE; CASE REPORT; CESAREAN SECTION; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; FEMALE; FLUID RESUSCITATION; HEART DISEASE; HEART FAILURE; HEART FUNCTION; HEART SURGERY; HEMODYNAMICS; HUMAN; MALE; NEWBORN; PATENT DUCTUS ARTERIOSUS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; TREATMENT OUTCOME; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

CESAREAN SECTION; CRITICAL ILLNESS; DELIVERY, OBSTETRIC; DUCTUS ARTERIOSUS; ECHOCARDIOGRAPHY; FEMALE; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; TREATMENT OUTCOME;

EID: 34250636242     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000098173     Document Type: Article

References (24)

1. Reller MD, Rice MJ, McDonald RW: Review of studies evaluating ductal patency in the premature infant. J Pediatr 1993;122:S59-S62.
2. Lim MK, Hanretty K, Houston AB, Lilley S, Murtagh EP: Intermittent ductal patency in healthy newborn infants: demonstration by colour Doppler flow mapping. Arch Dis Child 1992;67:1217-1218.
3. Walther FJ, Benders MJ, Leighton JO: Early changes in the neonatal circulatory transition. J Pediatr 1993;123:625-632.
4. Evans N, Iyer P: Longitudinal changes in the diameter of the ductus arteriosus in ventilated preterm infants: correlation with respiratory outcomes. Arch Dis Child Fetal Neonatal Ed 1995;72:F156-F161.
5. Clyman RI, Mauray F, Heymann MA, Roman C: Influence of increased pulmonary vascular pressures on the closure of the ductus arteriosus in newborn lambs. Pediatr Res 1989;25:136-142.
6. Levin DL, Heymann MA, Kitterman JA, Gregory GA, Phibbs RH, Rudolph AM: Persistent pulmonary hypertension of the newborn infant. J Pediatr 1976;89:626-630.
7. Toyoshima K, Momma K, Imamura S, Nakanishi T: In vivo dilatation of the fetal and postnatal ductus arteriosus by inhibition of phosphodiesterase 3 in rats. Biol Neonate 2005;89:251-256.
8. Momma K, Toyono M: The role of nitric oxide in dilating the fetal ductus arteriosus in rats. Pediatr Res 1999;46:311-315.
9. Milstein JM, Goetzman BW, Riemenschneider TA, Wennberg RP: Increased systemic vascular resistance in neonates with pulmonary hypertension. Am J Cardiol 1979;44:1159-1162.
10. Perreault T, Berkenbosch JW, Barrington KJ, Decker ER, Wu C, Brock TA, et al: TBC3711, an ET(A) receptor antagonist, reduces neonatal hypoxia-induced pulmonary hypertension in piglets. Pediatr Res 2001;50:374-383.
11. Christou H, Adatia I, Van Marter LJ, Kane JW, Thompson JE, Stark AR, et al: Effect of inhaled nitric oxide on endothelin-1 and cyclic guanosine 5′-monophosphate plasma concentrations in newborn infants with persistent pulmonary hypertension. J Pediatr 1997;130:603-611.
12. Finer NN, Barrington KJ: Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev 2000;CD000399.
13. Riemenscneider TA, Nielsen HC, Ruttenberg HD, Jaffe RB: Disturbances of the transitional circulation: spectrum of pulmonary hypertension and myocardial dysfunction. J Pediatr 1976;89:622-625.
14. Clyman RI, Roman C, Heymann MA, Mauray F: How a patent ductus arteriosus effects the premature lamb's ability to handle additional volume loads. Pediatr Res 1987;22:531-535.
15. Takahashi Y, Harada K, Shiota T, Tamura M, Noguchi H, Ishida A, et al: Left ventricular contractile state of early human neonates with patent ductus arteriosus. Tohoku J Exp Med 1994;172:155-161.
16. Hoffman TM, Wernovsky G, Atz AM, Kulik TJ, Nelson DP, Chang AC, et al: Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 2003;107:996-1002.
17. Bassler D, Choong K, McNamara P, Kirpalani H: Neonatal persistent pulmonary hypertension treated with milrinone: four case reports. Biol Neonate 2005;89:1-5.
18. McNamara PJ, Laique F, Muang-In S, Whyte HE: Milrinone improves oxygenation in neonates with severe persistent pulmonary hypertension of the newborn. J Crit Care 2006;21:217-222.
19. Brooks JM, Travadi JN, Patole SK, Doherty DA, Simmer K: Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management. Arch Dis Child Fetal Neonatal Ed 2005;90:F235-F239.
20. Laughon MM, Simmons MA, Bose CL: Patency of the ductus arteriosus in the premature infant: is it pathologic? Should it be treated? Curr Opin Pediatr 2004;16:146-151.
21. Norwood WI Jr, Jacobs ML, Murphy JD: Fontan procedure for hypoplastic left heart syndrome. Ann Thorac Surg 1992;54:1025-1029.
22. McCarthy JS, Zies LG, Gelband H: Age-dependent closure of the patent ductus arteriosus by indomethacin. Pediatrics 1978;62:706-712.
23. Bouayad A, Kajino H, Waleh N, Fouron JC, Andelfinger G, Varma DR, et al: Characterization of PGE2 receptors in fetal and newborn lamb ductus arteriosus. Am J Physiol Heart Circ Physiol 2001;280:H2342-H2349.
24. Koehne PS, Bein G, Alexi-Meskhishvili V, Weng Y, Buhrer C, Obladen M: Patent ductus arteriosus in very low birthweight infants: complications of pharmacological and surgical treatment. J Perinat Med 2001;29:327-334.